North American Comfilcon A Clinical Study
Launched by COOPERVISION INTERNATIONAL LIMITED (CVIL) · Mar 27, 2025
Trial Information
Current as of April 26, 2025
Recruiting
Keywords
ClinConnect Summary
The North American Comfilcon A Clinical Study is testing different types of contact lenses—specifically, comfilcon A Sphere, Toric, Multifocal, Toric Multifocal, and Energys lenses—to see how safe and effective they are for people with vision problems like astigmatism, presbyopia, and ametropia. The goal is to ensure that these lenses work well for everyday use in the general population.
To participate in this study, you need to be between 8 and 75 years old and have been using one of the specified contact lenses for at least a year, including wearing them overnight occasionally. However, if you are currently involved in another clinical trial for contact lenses or their care products, you won’t be eligible. If you join the trial, you can expect to help researchers understand how these lenses perform, which could lead to better options for people who need vision correction.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 8 to 75 years (inclusive).
- • 2. Current wearer of the Comfilcon A sphere, toric, multifocal, toric multifocal or Energys contact lens for at least 12 months.
- • 3. At least occasional overnight wear in the last 12 months.
- Exclusion Criteria:
- • 1. Current participation in a contact lens or contact lens care product clinical trial.
About Coopervision International Limited (Cvil)
CooperVision International Limited (CVIL) is a leading global manufacturer of contact lenses and related products, dedicated to enhancing vision health and improving the quality of life for wearers worldwide. With a strong commitment to innovation and research, CVIL invests in clinical trials to develop advanced lens technologies and solutions tailored to diverse vision needs. The company operates with a focus on safety, efficacy, and customer satisfaction, ensuring that their products meet the highest standards of quality and performance. Through partnerships and collaborations, CVIL continues to drive advancements in the eye care industry while prioritizing patient outcomes and satisfaction.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Granville, Ohio, United States
College, Pennsylvania, United States
Berkeley, California, United States
Patients applied
Trial Officials
Meng C Lin, OD, PhD
Principal Investigator
University of Berkeley
Katherine Bickle, Dr.
Principal Investigator
ProCare Vision Center
Abigail G Harsch, Dr.
Principal Investigator
Nittany Eye Associates
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported